OJ-415 Electrocardiographic Events and Cholesterol Reduction with Pravastatin in Patients with Hypercholesterolemia : Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial(Preventive Medicine/Epidemiology/Education 3 (H) : OJ50)(Or

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2004-03-01

著者

• ORIGASA Hideki

  Division of Biostatistics and Clinical Epidemiology, University of Toyama School of Medicine

• Shimizu Masami

  Molecular Genetics of Cardiovascular Disorders, Division of Cardiovascular Medicine, Graduate School

• Mabuchi Hiroshi

  Molecular Genetics of Cardiovascular Disorders, Division of Cardiovascular Medicine, Graduate School

• Origasa Hideki

  Division Of Biostatistics Toyama Medical And Pharmaceutical University

• Shimizu Masami

  Cardiovascular Checkup Committee For School Pupils Of Kanazawa Medical Association

• Mizuno Sumio

  福井心臓血圧センター

• Mizuno Sumio

  金沢大学 循環器内科

• Mabuchi Hiroshi

  Departments Of Lipidology Kanazawa University Graduate School Of Medical Science

• Shimizu Masami

  Molecular Genetics Of Cardiovascular Disorders Division Of Cardiovascular Medicine Graduate School O

• Origasa Hideki

  Division Of Biostatistics And Clinical Epidemiology University Of Toyama Graduate School Of Medicine

• Mabuchi Hiroshi

  Molecular Genetics Of Cardiovascular Disorders Division Of Cardiovascular Medicine Graduate School O

関連論文

• Clinical Importance of Adherence to Treatment With Eicosapentaenoic Acid by Patients With Hypercholesterolemia
• A health-related quality of life questionnaire in symptomatic patients with heart failure : Validity and reliability of a Japanese version of the MRF28
• Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease : Secondary Prevention Analysis From JELIS
• 4 Effects of EPA on coronary artery disease in patients with gluco-metabolism derangement : JELIS subgroup analysis(Late Breaking Clinical Trials II,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• 4 Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors : Sub-analysis of primary prevention cases from JELIS(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanes
• 3 Effectiveness of eicosapentaenoic acid in preventing coronary artery disease : Secondary prevention strata from JELIS.(Late Breaking Clinical Trials I,Special Program,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-056 Effects of Eicosapentaenoic Acid on Coronary Artery Disease in Patients with Arteriosclerosis Obliterans : JELIS Subgroup Analysis(FRS12,New Approaches to Atherosclerosis Research (IHD),Featured Research Session (English),The 73rd Annual Scientifi
• PJ-643 Prediction of Cardiac Events in Patients with Hypertrophic Cardiomyopathy : Usefulness of MIBG Myocardial Scintigraphy(Cardiomyopathy, basic/clinical-7 (M) PJ108,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
• PE-067 Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy Caused by Cardiac Troponinl Gene Mutation(Cardiomyopathy, basic/clinical-3 (M) PE12,Poster Session (English),The 70th Anniversary Annual Scientific Meeting
• OJ-223 A Novel Missense Mutation Met1107Thr in Cardiac Ryanodine Receptor Gene is Associated with Hypertrophic Cardiomyopathy(Cardiomyopathy, basic/clinical-2 (M) OJ38,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japa
• OE-284 Usefulness of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Patients with Hypertrophic Cardiomyopathy Associated with TNNI3 Gene Mutation(MRI/MRA-1 (I) OE48,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeti
• OE-265 Genotype-Phenotype Variations in Cardiomyopathies Caused by a Cardiac Troponin I Gene Mutation(Cardiomyopathy, basic/clinical-1 (M) OE45,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-104 Association between Angiotensin II Receptor Gene Polymorphism and Left Ventricular Systolic Dysfunction in Sarcomere Gene Mutation-induced Hypertrophic Cardiomyopathy(Frontier of Cardiomyopathy Research-2 (M) FRS21,Featured Research Session (Engli
• PJ-424 Cardiac Sympathetic Nerve Activity in Patients with Hypertrophic Cardiomyopathy Caused by Thin Filament Gene Mutations(Cardiomyopathy, Clinical 5 (M) : PJ71)(Poster Session (Japanese))
• PJ-643 Prediction of Cardiac Events in Patients with Hypertrophic Cardiomyopathy : Usefulness of MIBG Myocardial Scintigraphy(Cardiomyopathy, basic/clinical-7 (M) PJ108,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
• PJ-643 Prediction of Cardiac Events in Patients with Hypertrophic Cardiomyopathy : Usefulness of MIBG Myocardial Scintigraphy(Cardiomyopathy, basic/clinical-7 (M) PJ108,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
• PJ-643 Prediction of Cardiac Events in Patients with Hypertrophic Cardiomyopathy : Usefulness of MIBG Myocardial Scintigraphy(Cardiomyopathy, basic/clinical-7 (M) PJ108,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japane
• FRS-149 Mutation Site-Specific Differences in Arrhythmic Risk and Sensitivity to Sympathetic Stimulation in Japanese Families with Congenital LQT1 Syndrome(Sudden Cardiac Death (A) : FRS18)(Featured Research Session (English))
• 5 Genotype- and Mutation site-Specific Differences in Arrhythmic Risk and Sensitivity to Sympathetic Stimulation in the Long QT Syndrome(APSC/JCS Joint Symposium (APSC) (H) : Emerging Issue in Cardiology for Asian)(Special Program)
• PJ-512 The Relationship between Plasma Fatty Acids Composition and Serum Lipoproteins in Hyperchoresterolemic Patients : Findings from JELIS(Lipid disorders-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-040 Relationships Between Coronary Artery Disease (CAD) and Serum Lipid Concentrations, and Preventive Effects of EPA in Hypercholesterolemic Patients : JELIS Sub-Analysis(Preventive Medicine, The 71st Annual Scientific Meeting of the Japanese Circula
• 2 Major Outcomes and Safety of EPA Derived from the Japan EPA LIPID INTERVENTION STUDY (JELIS)(Late Breaking Clinical Trials in Japan,The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Lispro is superior to regular insulin in transient intensive insulin therapy in type 2 diabetes
• Abnormal sympathetic innervation of the heart in a patient with Emery-Dreifuss muscular dystrophy
• Risk Evaluation of Coronary Heart Disease and Cerebrovascular Disease by the Japan Atherosclerosis Society Guidelines 2002 Using the Cohort of the Holicos-PAT Study
• Differentiation between patients with takotsubo cardiomyopathy and those with anterior acute myocardial infarction
• PE-279 High Incidence of Sudden Cardiac Death with Conduction Disturbances and Atrial Cardiomyopathy Caused by a Mutation in the STA Gene(Cardiomyopathy, Clinical 3 (M) : PE48)(Poster Session (English))
• Reduction of hemolysis without reoperation following mitral valve repair
• Identification of two novel missense mutations (p.R1221C and p.R1357W) in the ABCC6 (MRP6) gene in a Japanese patient with pseudoxanthoma elasticum (PXE)
• Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis - A 28-year clinical course
• Japan Lipid Intervention Trial (J-LIT) Chart Predicts the Absence of Coronary Artery Disease More Accurately Than Symptom Limited Exercise Stress Electrocardiography
• In-hospital Outcome in Octogenarians with Acute Coronary Syndrome Undergoing Emergent Coronary Angiography
• Gene mutations in adult Japanese patients with dilated cardiomyopathy
• Oxidative Stress Correlates with Left Ventricular Volume after Acute Myocardial Infarction
• Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 (ABCA1) gene in Japanese patients with Tangier disease
• Assessment of effects of traditional herbal medicines on elderly patients with weakness using a self-controlled trial
• Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia
• FRS-128 Mutations in Phospholamban Gene Cause Hypertrophic and Dilated Cardiomyopathy(Myocardial Disease (M) : FRS16)(Featured Research Session (English))
• Involvement of Meteorological Factors and Sex in the Occurrence of Subarachnoid Hemorrhage in Japan
• Characteristics of Helmet or Knit Cap Use in Head Injury of Snowboarders : Analysis of 1,190 Consecutive Patients
• Duration of Cerebrospinal Fluid Drainage in Patients With Aneurysmal Subarachnoid Hemorrhage for Prevention of Symptomatic Vasospasm and Late Hydrocephalus
• Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
• Increased Circulating Matrix Metalloproteinase-2 in Patients with Hypertrophic Cardiomyopathy with Systolic Dysfunction
• Effects of the Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms and Functional Capacity in Japanese Patients With Severe Pulmonary Hypertension
• PE-437 Effects of Endothelin Receptor Antagonist Bosentan on Hemodynamics, Symptoms, and Quality of Life in Patients with Severe Pulmonary Hypertension(Pulmonary Circulation 3 (H) : PE74)(Poster Session (English))
• Scintigraphic evaluation of regression of abnormal Q waves in myocardial infarction
• PJ-425 Early Development of Dilated Cardiomyopathy in Subjects with Mutations in the Cardiac Troponin Complex Genes(Cardiomyopathy, Clinical 5 (M) : PJ71)(Poster Session (Japanese))
• OJ-511 Missense Mutations in Cardiac Ryanodine Receptor Gene Cause Hypertrophic Cardiomyopathy Associated with Ventricular Arrhythmia or Massive Hypertrophy(Cardiomyopathy, Basic (M) : OJ62)(Oral Presentation (Japanese))
• OJ-229 Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy with Different Genotypes(Cardiomyopathy, Clinical 1 (M) : OJ26)(Oral Presentation (Japanese))
• OJ-078 Usefulness of Q-T Peak Dispersion for Diagnosis of KCNH2 Gene Mutations in Patients with Long QT Syndrome(Arrhythmia, Basic 1 (A) : OJ10)(Oral Presentation (Japanese))
• FRS-129 Mutations Responsible for Dilated Cardiomyopathy in Japan(Myocardial Disease (M) : FRS16)(Featured Research Session (English))
• PJ-596 Exercise-induced Systolic Dysfunction in Patients with Non-obstructive Hypertrophic Cardiomyopathy and Mutations in the Cardiac Troponin Genes(Cardiomyopathy, Clinical 7 (M) : PJ100)(Poster Session (Japanese))
• OJ-335 PRKAR1A Gene Mutation in Patients with Cardiac Myxoma(Valvular Heart Disease/Pericarditis/Cardiac Tumor 2 (M) : OJ40)(Oral Presentation (Japanese))
• Alterations in Echocardiographic Tissue Characterization in Patients with Cardiac Troponin I Gene Mutation a Possible Indicator of Preclinical Hypertrophic Cardiomyopathy
• Cardiac Actin and Alpha-Tropomyosin Genes Are Associated with Neither Hypertrophic Nor Dilated Cardiomyopathy in Patients from Hokuriku District in Japan
• The Japan Thrombosis Registry for Atrial Fibrillation, Coronary or Cerebrovascular Events (J-TRACE) : A Nation-Wide, Prospective Large Cohort Study; The Study Design
• PE-280 Missense Mutations in the MYBPC3 Gene are Responsible for Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction and Dilatation(Cardiomyopathy, Clinical 3 (M) : PE48)(Poster Session (English))
• PE-278 Electrocardiography Shows Preferable Diagnostic Value Even in Carriers of Hypertrophic Cardiomyopathy who do not Manifest Ventricular Wall Hypertrophy on Echocardiography(Cardiomyopathy, Clinical 3 (M) : PE48)(Poster Session (English))
• OJ-237 KCNJ2 Gene Mutation is a Rare Cause of Long QT Syndrome(Arrhythmia, Diagnosis/Pathophysiology/EPS 9 (A) : OJ27)(Oral Presentation (Japanese))
• FRS-132 Phenotypic Discrepancies Between Electrocardiography and Echocardiography for Hypertrophic Cardiomyopathy in Genetically Affected Subjects(Myocardial Disease (M) : FRS16)(Featured Research Session (English))
• Left ventricular dysfunction and dilatation in elderly patients with hypertrophic cardiomyopathy associated with a novel missense mutation in MyBP-C gene
• Relationship between QT Variables and Disproportion of Left Ventricular Wall in Patients with Hypertrophic Cardiomyopathy
• Fluctuation of T-peak to T-end before and after ventricular tachycardia
• Q-T peak dispersion in congenital long QT syndrome ; increased lag of T wave peak as a new marker of HERG
• OE-057 Genetic Effects of Farnesoid-X-receptor on BMI, HDL-C, LDL-C and Development of Fatty Liver(Lipid disorders-1 (H) OE10,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• Pathophysiological Roles of the Adrenal Renin-Angiotensin System in Patients with Primary Aldosteronism
• Effects of Aldosterone Blockade on Cardiac Renin-Angiotensin-Aldosterone System in Salt-Sensitive Hypertension (Hypertension, Basic 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Probucol-Induced Long QT Syndrome Associated with a Novel Missense Mutation M124T in the N Terminus of HERG
• Long QT Syndrome Mutations in Different Sites of HERG Elicit a Variety of Functional Changes
• Double Missense Mutations (D611Y in KCNQ1 and D609G in HERG) in a Japanese Family with Long QT Syndrome
• Characterization of a Novel Missense Mutation E637K in the Pore-S6 Loop of HERG in a Patient with Long QT Syndrome
• Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome
• Crow-Fukase syndrome associated with high-output heart failure
• Prognostic Factors in Elderly Patients with Supratentorial Malignant Gliomas
• Sixteen-slice computed tomography, transthoracic real-time 3-dimensional echocardiography and magnetic resonance imaging assessment of a long-term survivor of rupture of sinus of valsalva aneurysm
• Increased matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction
• OJ-415 Electrocardiographic Events and Cholesterol Reduction with Pravastatin in Patients with Hypercholesterolemia : Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial(Preventive Medicine/Epidemiology/Education 3 (H) : OJ50)(Or
• Effect of Pravastatin-Induced LDL-Cholesterol Reduction on Coronary Heart Disease and Cerebrovascular Disease in Japanese : Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial(Holicos-PAT)
• PCSK9 Gene Mutation is Less Frequent in Clinically Diagnosed FH Patients without LDLR and ApoB-100 Gene Mutation in Japan(Lipid Disorders 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Usefulness of Acoustic Densitometry Method for Detection of Myocardial Changes in Preclinical Patients with Hypertrophic Cardiomyopathy
• Difference in Coronary Blood Flow Dynamics between Patients with Hypertension and Those with Hypertrophic Cardiomyopathy
• Q-T peak dispersion in congenital long QT syndrome: Possible marker of mutation of HERG
• Cardiac Manifestations and Long-Term Course in Emery-Dreifuss Muscular Dystrophy Caused by a Nonsense Mutation in the STA Gene
• Effects of gender on the number of diseased vessels and clinical outcome in Japanese patients with acute coronary syndrome
• A novel de novo mutation in the cardiac β - myosin heavy chain gene in patients with dilated cardiomyopathy
• Mitochondrial DNA mutations in hypertrophic cardiomyopathy
• Novel KCNQ1 missense mutation (D611Y) in a Japanese long QT family
• Whole and regional variation of cardiac sympathetic nervous activity in patients with hypertrophic cardiomyopathy with malignant tachyarrthythmias and sudden death
• Association between Single Nucleotide Polymorphisms (SNPs) of Cardiac Potassium Channel Genes and Drug-Induced Long QT Syndrome in Japanese
• A Novel Mutation (lnt21DSG+1A) in the MyBP-C Gene Shows Hypertrophic Cardiomyopathy with a High Degree of Penetrance in Adult Patients
• Diagnostic Values of Abnormal Q Waves for Hypertrophic Cardiomyopathy Based on the Genetic Information
• QT Variables in Preclinical Patients with Hypertrophic Cardiomyopathy
• QT Variables in Various Genotyped Patients with Hypertrophic Cardiomyopathy
• Mitochondrial DNA Mutations in Hypertrophic Cardiomyopathy
• Frequency of Asymmetric Septal Hypertrophy in Patients with Hypertrophic Cardiomyopathy : Difference in Genotypes
• Differences in Diagnostic Values of Abnormal Q Waves between Hypertrophic Cardiomyopathy with a cTnl Gene Mutation and MyBP-C Gene Mutations
• Clinical and Electrophysiological Characteristics of Brugada Syndrome Caused by a Missense Mutation in the S5-pore site of SCN5A(Arrhythmia, Diagnosis/Pathophysiology/EPS 5 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-144 A Novel Missense Mutation of SCN5A Gene Associated with Brugada Syndrome by Bidirectional Effects on Blocking Actions of Antiarrhythmic Drugs(Sudden Cardiac Death (A) : FRS18)(Featured Research Session (English))
• Investigation of optimal anticoagulation strategy for stroke prevention in Japanese patients with atrial fibrillation : The J-RHYTHM Registry study design
• Preventive Effects of Eicosapentaenoic Acid on Coronary Artery Disease in Patients With Peripheral Artery Disease : Subanalysis of the JELIS Trial

もっと見る 閉じる

スポンサーリンク